CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
Crossref DOI link: https://doi.org/10.1007/s10549-015-3562-5
Published Online: 2015-09-14
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dezentjé, V. O.
Opdam, F. L.
Gelderblom, H.
Hartigh den, J.
Van der Straaten, T.
Vree, R.
Maartense, E.
Smorenburg, C. H.
Putter, H.
Dieudonné, A. S.
Neven, P.
Van de Velde, C. J. H.
Nortier, J. W. R.
Guchelaar, H.-J.
License valid from 2015-09-14